Partnership for the Advancement of Cancer Research: NMSU & FHCRC (1 of 2)Pilot Project #5: Promotora outreach for cervical cancer screeningHugo Vilchis (NMSU) / Beti Thompson (FHCRC)ABSTRACTABSTRACTHispanic women in the United States (U.S.) experience nearly double the incidence of invasive cervical cancerexperienced by non-Hispanic whites. The problem is especially severe in the border communities of the U.S.and Mexico. Differences in prevalence of Papanicolaou (Pap) tests for early cervical lesion detection arethought, in part, to explain the differences in incidence, however, difference in participation in follow-up careamong women with abnormal cervical cytologic findings also may contribute to the disparity. The overall goalsof this outreach project are to increase pap testing and follow-up testing for abnormal pap smears amongwomen living in the border communities of New Mexico and Mexico. Specifically, using a promotora programto promote pap testing and follow-up for abnormal tests, we will:1. Primarily, increase the number of pap tests that occur in a specific border community clinic compared totwo non-intervention clinics; and2. Secondarily, increase the follow-up rates for abnormal pap smears in the specific Border clinic.Promotoras who work with the intervention clinic will be trained to provide information to and encouragewomen to receive pap testing. They also will be trained to work with the clinic to identify the results of the testsand to encourage women with abnormal tests to receive follow-up testing. Finally, they will refer women tousual care if the initial or follow-up tests are negative or refer women to treatment if the woman presents withcervical cancer. A number of agencies exist in the community to treat women with cervical cancer. The mainquestions of interest, corresponding to our specific aims are: 1). Is there increased pap testing as a result ofthe intervention? and 2). Is there increased follow-up testing (e.g., repeat pap or colposcopy) as a result of theintervention? A secondary aim is to answer question 3): What is the pattern(s) for treatment of cervicalcancer? During the first six months of this three year project, information will be gathered on existing pap testrates in the three clinics that will participate. The next 24 months will consist of intervention in one clinic toincrease pap screening rates and follow-up rates for abnormal tests and to follow treatment patterns. Duringthe final 6 months, we will assess differences in pap screening and abnorma pap follow-up rates.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
1U54CA132383-01
Application #
7422088
Study Section
Special Emphasis Panel (ZCA1-SRRB-Y (O1))
Project Start
2007-09-30
Project End
2012-08-31
Budget Start
2007-09-30
Budget End
2008-08-31
Support Year
1
Fiscal Year
2007
Total Cost
$86,498
Indirect Cost
Name
New Mexico State University Las Cruces
Department
Type
DUNS #
173851965
City
Las Cruces
State
NM
Country
United States
Zip Code
88003
Ortega, Sigolène; McAlvain, Megan Stamey; Briant, Katherine J et al. (2018) Perspectives of Community Advisory Board Members in a Community-Academic Partnership. J Health Care Poor Underserved 29:1529-1543
Sanchez, N S; Quinn, K E; Ashley, A K et al. (2018) In the ovine pituitary, CXCR4 is localized in gonadotropes and somatotropes and increases with elevated serum progesterone. Domest Anim Endocrinol 62:88-97
Molina, Yamile; Briant, Katherine J; Sanchez, Janeth I et al. (2018) Knowledge and social engagement change in intention to be screened for colorectal cancer. Ethn Health 23:461-479
Gurley, Kay E; Ashley, Amanda K; Moser, Russell D et al. (2017) Synergy between Prkdc and Trp53 regulates stem cell proliferation and GI-ARS after irradiation. Cell Death Differ 24:1853-1860
Phan, Tuan Anh; Tian, Jianjun Paul (2017) The Role of the Innate Immune System in Oncolytic Virotherapy. Comput Math Methods Med 2017:6587258
Quinn, K E; Reynolds, L P; Grazul-Bilska, A T et al. (2016) Placental development during early pregnancy: Effects of embryo origin on expression of chemokine ligand twelve (CXCL12). Placenta 43:77-80
Salazar, Monica; Lerma-Ortiz, Alejandra; Hooks, Grace M et al. (2016) Progestin-mediated activation of MAPK and AKT in nuclear progesterone receptor negative breast epithelial cells: The role of membrane progesterone receptors. Gene 591:6-13
Adams, Scott V; Barrick, Brian; Christopher, Emily P et al. (2016) Urinary heavy metals in Hispanics 40-85 years old in Doña Ana County, New Mexico. Arch Environ Occup Health 71:338-346
Cao, Ruofan; Jenkins, Patrick; Peria, William et al. (2016) Phasor plotting with frequency-domain flow cytometry. Opt Express 24:14596-607
Qian, Lei; Bradford, Andrew M; Cooke, Peter H et al. (2016) Grb7 and Hax1 may colocalize partially to mitochondria in EGF-treated SKBR3 cells and their interaction can affect Caspase3 cleavage of Hax1. J Mol Recognit 29:318-33

Showing the most recent 10 out of 82 publications